Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-31 Gros David-Alexandre C Chief Executive Officer Grant or award +354,454 363,454
2026-07-31 Gros David-Alexandre C Chief Executive Officer Shares withheld for taxes −194,791 $3.38 $658K 168,663
2025-01-10 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +600,000 600,000
2025-01-10 Gros David-Alexandre C Chief Executive Officer Grant or award · Restricted Stock Units +66,500 66,500
2024-11-21 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +1,015,743 1,015,743
2024-06-13 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +517,454 517,454
2023-05-01 Gros David-Alexandre C Chief Executive Officer Grant or award · Common Stock (right to buy) +383,299 383,299
2023-02-01 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +300,000 300,000
2023-02-01 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +153,600 153,600
2022-02-01 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (right to buy) +108,000 108,000
2021-12-20 Gros David-Alexandre C Chief Executive Officer Purchase +2,000 $4.48 $9K 9,000
2021-08-17 Gros David-Alexandre C Chief Executive Officer Purchase +4,000 $6.21 $25K 7,000
2021-06-09 Gros David-Alexandre C Chief Executive Officer Purchase +3,000 $8.01 $24K 3,000
2020-09-11 Gros David-Alexandre C Chief Executive Officer Grant or award · Stock Option (Right to Buy) +18,278.14 18,278.14

Page 1 of 1 · 14 trades